1Bazzano LA, He J, Ogden LG, et al. (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr 76, 93–99.
2Carter P, Gray LJ, Troughton J, et al. (2010) Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ 341, c4229.
3Williams DE, Wareham NJ, Cox BD, et al. (1999) Frequent salad vegetable consumption is associated with a reduction in the risk of diabetes mellitus. J Clin Epidemiol 52, 329–335.
4Vinson JA, Hao Y, Su X, et al. (1998) Phenol antioxidant quantity and quality in foods: vegetables. J Agric Food Chem 46, 3630–3634.
5Pellegrini N, Serafini M, Colombi B, et al. (2003) Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr 133, 2812–2819.
6Pant G, Panwar MS, Negi DS, et al. (1988) Spirostanol glycoside from fruits of Asparagus officinalis. Phytochemistry 27, 3324–3325.
7Shao Y, Poobrasert O, Kennelly EJ, et al. (1997) Steroidal saponins from Asparagus officinalis and their cytotoxic activity. Planta Med 63, 258–262.
8Shiomi N, Yamada J & Izawa MA (1979) Novel pentasaccharide in the roots of asparagus (Asparagus officinalis L.). Agric Biol Chem 43, 1375–1377.
9Shiomi N (1981) Two novel hexasaccharides from the roots of Asparagus officinalis. Phytochemistry 20, 2581–2583.
10Fukushi E, Onodera S, Yamamori A, et al. (2000) NMR analysis of tri- and tetrasaccharides from asparagus. Magn Reson Chem 38, 1005–1011.
11Terada K, Honda C, Suwa K, et al. (1995) Acetylenic compounds isolated from cultured cells of Asparagus officinalis. Chem Pharm Bull 43, 564–566.
12Yanagawa H, Kato T, Kitahara Y, et al. (1972) Asparagusic acid, dihydroasparagusic acid, and S-acetyldihydroasparagusic acid, new plant growth inhibitors in etiolated young Asparagus officinalis. Tetrahedron Lett 13, 2549–2552.
13Yanagawa H, Kato T & Kitahara Y (1973) Asparagusic acid S-oxides, new plant growth regulators in etiolated young asparagus shoots. Tetrahedron Lett 14, 1073–1075.
14Kasai T, Hirakuri Y & Sakamura S (1983) Two cysteine derivatives in asparagus shoots. Phytochemistry 22, 2563–2564.
15Matsubayashi Y & Sakagami Y (1996) Phytosulfokine, sulfated peptides that induce the proliferation of single mesophyll cells of Asparagus officinalis L. Proc Natl Acad Sci U S A 93, 7623–7627.
16Gang ZZ, Li LZ & Xian LX (1997) Study on the isolation, purification and antioxidation properties of polysaccharides from Spirulina maxima. Acta Botanica Sinica 39, 77–81.
17Liu SX, Chen Y, Zhou M, et al. (1997) Protective effect of the polysaccharide kreskin on inhibition of lipopolysaccharide-induced nitric oxide production in macrophages caused by oxidized low-density lipoprotein. Med Sci Res 25, 507–509.
18Zeng N, Meng X & Zhang Y (1997) Studies on the antioxidative effect of constituents of Herba epimedii (ESPS). Zhongguo Zhongyao Zazhi 22, 46–48.
19Said O, Khalil K, Fulder S, et al. (2002) Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region. J Ethnopharmacol 83, 251–265.
20Shao Y, Chin CK, Ho CT, et al. (1996) Anti-tumor activity of the crude saponins obtained from asparagus. Cancer Lett 24, 31–36.
21Wang H & Ng TB (2001) Isolation of a novel deoxyribonuclease with antifungal activity from Asparagus officinalis seeds. Biochem Biophys Res Commun 23, 120–124.
22Balansard S & Rayband M (1987) Diuretic action of Asparagus officinalis. Crit Rev Soc Biol 126, 954–956.
23Thatte UM & Dahanukar SA (1988) Comparative study of immunomodulating activity of Indian medicinal plants, lithium carbonate and glucan. Methods Find Exp Clin Pharmacol 10, 639–644.
24Rege NN, Thatte UM & Dahanukar SA (1999) Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 3, 275–291.
25Rodríguez R, Jaramillo S, Rodríguez G, et al. (2005) Antioxidant activity of ethanolic extracts from several asparagus cultivars. J Agric Food Chem 29, 5212–5217.
26Ali SI & Khan SW (2009) Asparagaceae. In Flora of Pakistan, no. 217, pp. 1–23 [, editors]. Karachi: BCC&T Press.
27Zhao J, Zhang W, Zhu X, et al. (2011) The aqueous extract of Asparagus officinalis L. by-product exerts hypoglycaemic activity in streptozotocin-induced diabetic rats. J Sci Food Agric 91, 2095–2099.
28Portha B, Blondel O, Serradas P, et al. (1989) The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabetes Metab 15, 61–75.
29Kodama T, Iwase M, Nunoi K, et al. (1993) A new diabetes model induced by neonatal alloxan treatment in rats. Diabetes Res Clin Pract 20, 183–189.
30Arulmozhi DK, Veeranjaneyulu A & Bodhankar SL (2004) Neonatal streptozotocin-induced rat model of type 2 diabetes mellitus: a glance. Indian J Pharmacol 36, 217–221.
31Portha B, Movassat J, Cuzin-Tourrel C, et al. (2007) Neonatally streptozotocin-induced (n-STZ) diabetic rats: a family of type 2 diabetes models. In Animal Models of Diabetes, 2nd ed., pp. 223–250 [, editor]. Boca Raton, FL: CRC Press.
32Fenglin H, Ruili L, Bao H, et al. (2004) Free radical scavenging activity of extracts prepared from fresh leaves of selected Chinese medicinal plants. Fitoterapia 75, 14–23.
33Atta-ur-Rahman , Zareen S, Choudhary MI, et al. (2008) Alpha-glucosidase inhibitory activity of triterpenoids from Cichorium intybus. J Nat Prod 71, 910–913.
34Bonner-Weir S, Trent DF, Honey RN, et al. (1981) Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes 30, 64–69.
35Roy MN, Biswas KB, Siddiqua N, et al. (2007) Determinants of insulin secretion and sensitivity in Bangladeshi type 2 diabetic subjects. Metab Syndr Relat Disord 5, 275–281.
36Karim MR, Zinnat R, Akter S, et al. (2011) Characterization of insulin secretion in type 2 diabetic subjects. Bang J Med Biochem 2, 21–25.
37Hannan JM, Marenah L, Ali L, et al. (2007) Insulin secretory actions of extracts of Asparagus racemosus root in perfused pancreas, isolated islets and clonal pancreatic beta-cells. J Endocrinol 192, 159–168.
38Papaccio G & Mezzogiorno M (1992) Morphological aspect of glucagon and somatostatin islet cells in diabetic biobreeding and low-dose streptozotocin-treated Wistar rats. Pancreas 4, 289–294.
39Pons P & Aoki A (1995) Differential proliferation of somatostatin and glucagon cells in rat pancreatic islets submitted to different stimuli. Ann Anat 177, 221–227.
40Singh N & Gupta M (2007) Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits. Indian J Exp Biol 45, 1055–1062.
41Shanmugasundaram ER, Gopinath KL, Radha SK, et al. (1990) Possible regeneration of the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. J Ethnopharmacol 30, 265–279.
42Hafizur RM, Kabir N & Chishti S (2011) Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp. Nat Prod Res 25, 353–367.
43Gardner PT, White TAC, McPhail DB, et al. (2000) The relative contributions of vitamin C, carotenoids and phenolics to the antioxidant potential of fruit juices. Food Chem 68, 471–474.
44Martinez-Valverde I, Periago MJ, Provan G, et al. (2002) Phenolic compounds, lycopene and antioxidant activity in commercial varieties of tomato (Lycopersicon esculentum). J Sci Food Agric 82, 323–330.